De FDA approved Aducanumab iwhich is the first new Alzheimer’s treatment in 18 years and the first to attack the disease process. But some prominent experts say there’s not enough evidence it can address cognitive symptoms.
https://www.nytimes.com/2021/06/07/health/fda-approves-alzheimers-drug.html?smid=em-share
- Forums
- ASX - By Stock
- MSB
- Alzheimer drug approved
Alzheimer drug approved
- There are more pages in this discussion • 243 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.18 |
Change
0.020(1.73%) |
Mkt cap ! $1.341B |
Open | High | Low | Value | Volume |
$1.20 | $1.21 | $1.17 | $16.67M | 14.04M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 54704 | $1.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5590 | 1.230 |
2 | 21069 | 1.215 |
2 | 22396 | 1.210 |
2 | 18700 | 1.200 |
1 | 5 | 1.195 |
Price($) | Vol. | No. |
---|---|---|
1.100 | 70 | 1 |
1.140 | 1282 | 1 |
1.160 | 15 | 1 |
1.175 | 5000 | 1 |
1.180 | 1290 | 2 |
Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.19 |
  |
Change
0.020 ( 3.40 %) |
|||
Open | High | Low | Volume | ||
$1.21 | $1.21 | $1.17 | 2927691 | ||
Last updated 15.59pm 07/05/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online